These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


155 related items for PubMed ID: 32234415

  • 1. The challenge of long-term adherence: The role of bone turnover markers in monitoring bisphosphonate treatment of osteoporosis.
    Fontalis A, Eastell R.
    Bone; 2020 Jul; 136():115336. PubMed ID: 32234415
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Response of bone turnover markers to three oral bisphosphonate therapies in postmenopausal osteoporosis: the TRIO study.
    Naylor KE, Jacques RM, Paggiosi M, Gossiel F, Peel NF, McCloskey EV, Walsh JS, Eastell R.
    Osteoporos Int; 2016 Jan; 27(1):21-31. PubMed ID: 25990354
    [Abstract] [Full Text] [Related]

  • 4. Bisphosphonates for prevention of postmenopausal osteoporosis.
    Ravn P.
    Dan Med Bull; 2002 Feb; 49(1):1-18. PubMed ID: 11894721
    [Abstract] [Full Text] [Related]

  • 5. Effects of pharmaceutical care on adherence and persistence to bisphosphonates in postmenopausal osteoporotic women.
    Lai PS, Chua SS, Chew YY, Chan SP.
    J Clin Pharm Ther; 2011 Oct; 36(5):557-67. PubMed ID: 21916908
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Once-monthly oral ibandronate in postmenopausal osteoporosis: translation and updated review.
    Rossini M, Viapiana O, Gatti D, Adami S.
    Clin Ther; 2009 Jul; 31(7):1497-510. PubMed ID: 19695399
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Efficacy of bisphosphonates in reducing fracture risk in postmenopausal osteoporosis.
    Bilezikian JP.
    Am J Med; 2009 Feb; 122(2 Suppl):S14-21. PubMed ID: 19187808
    [Abstract] [Full Text] [Related]

  • 13. Comparative efficacy of bisphosphonates in short-term fracture prevention for primary osteoporosis: a systematic review with network meta-analyses.
    Zhou J, Ma X, Wang T, Zhai S.
    Osteoporos Int; 2016 Nov; 27(11):3289-3300. PubMed ID: 27273112
    [Abstract] [Full Text] [Related]

  • 14. Efficacy and safety of alendronate and risedronate for postmenopausal osteoporosis.
    Iwamoto J, Takeda T, Sato Y.
    Curr Med Res Opin; 2006 May; 22(5):919-28. PubMed ID: 16709313
    [Abstract] [Full Text] [Related]

  • 15. Clinical pharmacology of potent new bisphosphonates for postmenopausal osteoporosis.
    Chapurlat RD.
    Treat Endocrinol; 2005 May; 4(2):115-25. PubMed ID: 15783248
    [Abstract] [Full Text] [Related]

  • 16. Bisphosphonates for osteoporosis in primary biliary cirrhosis.
    Rudic JS, Giljaca V, Krstic MN, Bjelakovic G, Gluud C.
    Cochrane Database Syst Rev; 2011 Dec 07; (12):CD009144. PubMed ID: 22161446
    [Abstract] [Full Text] [Related]

  • 17. Drug insight: Bisphosphonates for postmenopausal osteoporosis.
    Chapurlat RD, Delmas PD.
    Nat Clin Pract Endocrinol Metab; 2006 Apr 07; 2(4):211-9; quiz following 238. PubMed ID: 16932286
    [Abstract] [Full Text] [Related]

  • 18. Significance of a decline in bone mineral density while receiving oral bisphosphonate treatment.
    Sebba AI.
    Clin Ther; 2008 Mar 07; 30(3):443-52. PubMed ID: 18405784
    [Abstract] [Full Text] [Related]

  • 19. Ibandronate treatment for osteoporosis: rationale, preclinical, and clinical development of extended dosing regimens.
    Epstein S.
    Curr Osteoporos Rep; 2006 Mar 07; 4(1):14-20. PubMed ID: 16527003
    [Abstract] [Full Text] [Related]

  • 20. Changes in urinary NTX levels in patients with primary osteoporosis undergoing long-term bisphosphonate treatment.
    Iba K, Takada J, Hatakeyama N, Ozasa Y, Wada T, Yamashita T.
    J Orthop Sci; 2008 Sep 07; 13(5):438-41. PubMed ID: 18843458
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 8.